Tencent's life sciences lab, in collaboration with Central South University, has published a novel AI virtual cell algorithm called UniPert–G2CP in the journal Cell. This algorithm uniquely maps gene and chemical drug perturbations into a unified semantic space, addressing the challenge of predicting cellular responses to combined treatments. The core UniPert module is open-source, and the G2CP approach utilizes transfer learning, pre-training on gene screening data and fine-tuning with chemical screening data. The research involved extensive data across multiple cancer cell lines and successfully validated its predictions and mechanistic explanations in ESR1 endocrine resistance cases. AI
IMPACT This research advances AI's application in drug discovery and personalized medicine by enabling more accurate prediction of cellular responses to combined genetic and chemical interventions.
RANK_REASON Publication of an AI algorithm in a high-impact academic journal. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
